FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3047101097> ?p ?o ?g. }

• W3047101097 endingPage "2171" @default.
• W3047101097 startingPage "2171" @default.
• W3047101097 abstract "Background: Acute myeloid leukemia (AML) remains a major clinical challenge due to poor overall survival, which is even more dramatic in elderly patients. TIGIT, an inhibitory receptor that interacts with CD155 and CD112 molecules, is considered as a checkpoint in T and NK cell activation. This receptor shares ligands with the co-stimulatory receptor DNAM-1 and with TACTILE. The aim of this work was to analyze the expression of DNAM-1, TIGIT and TACTILE in NK cells and T cell subsets in AML patients. Methods: We have studied 36 patients at the time of diagnosis of AML and 20 healthy volunteers. The expression of DNAM-1, TIGIT and TACTILE in NK cells and T cells, according to the expression of CD3 and CD56, was performed by flow cytometry. Results: NK cells, CD56− T cells and CD56+ T (NKT-like) cells from AML patients presented a reduced expression of DNAM-1 compared with healthy volunteers. An increased expression of TIGIT was observed in mainstream CD56− T cells. No differences were observed in the expression of TACTILE. Simplified presentation of incredibly complex evaluations (SPICE) analysis of the co-expression of DNAM-1, TIGIT and TACTILE showed an increase in NK and T cells lacking DNAM-1 and co-expressing TIGIT and TACTILE. Low percentages of DNAM-1−TIGIT+TACTILE+ NK cells and DNAM-1− TIGIT+TACTILE+ CD56− T cells were associated with a better survival of AML patients. Conclusions: The expression of DNAM-1 is reduced in NK cells and in CD4+ and CD8+ T cells from AML patients compared with those from healthy volunteers. An increased percentage of NK and T cells lacking DNAM-1 and co-expressing TIGIT and TACTILE is associated with patient survival, supporting the role of TIGIT as a novel candidate for checkpoint blockade." @default.
• W3047101097 created "2020-08-10" @default.
• W3047101097 creator A5013229327 @default.
• W3047101097 creator A5019797686 @default.
• W3047101097 creator A5024647317 @default.
• W3047101097 creator A5025363729 @default.
• W3047101097 creator A5027209719 @default.
• W3047101097 creator A5031935302 @default.
• W3047101097 creator A5041218872 @default.
• W3047101097 creator A5046863485 @default.
• W3047101097 creator A5049083520 @default.
• W3047101097 creator A5052872662 @default.
• W3047101097 creator A5065317886 @default.
• W3047101097 creator A5067045168 @default.
• W3047101097 creator A5068120048 @default.
• W3047101097 creator A5069030466 @default.
• W3047101097 creator A5077770534 @default.
• W3047101097 creator A5088300504 @default.
• W3047101097 creator A5089465112 @default.
• W3047101097 date "2020-08-05" @default.
• W3047101097 modified "2023-10-17" @default.
• W3047101097 title "Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia" @default.
• W3047101097 cites W1634951127 @default.
• W3047101097 cites W1863751964 @default.
• W3047101097 cites W1965031244 @default.
• W3047101097 cites W1981352048 @default.
• W3047101097 cites W1987165863 @default.
• W3047101097 cites W1999689279 @default.
• W3047101097 cites W2004191344 @default.
• W3047101097 cites W2007825988 @default.
• W3047101097 cites W2029399624 @default.
• W3047101097 cites W2039084448 @default.
• W3047101097 cites W2042037279 @default.
• W3047101097 cites W2050457398 @default.
• W3047101097 cites W2079618508 @default.
• W3047101097 cites W2081484203 @default.
• W3047101097 cites W2099854994 @default.
• W3047101097 cites W2123089812 @default.
• W3047101097 cites W2144201925 @default.
• W3047101097 cites W2239788766 @default.
• W3047101097 cites W2406361470 @default.
• W3047101097 cites W2465587303 @default.
• W3047101097 cites W2520704033 @default.
• W3047101097 cites W2523562238 @default.
• W3047101097 cites W2562411107 @default.
• W3047101097 cites W2737469573 @default.
• W3047101097 cites W2742727395 @default.
• W3047101097 cites W2752870072 @default.
• W3047101097 cites W2767090199 @default.
• W3047101097 cites W2767772633 @default.
• W3047101097 cites W2801918257 @default.
• W3047101097 cites W2888451395 @default.
• W3047101097 cites W2890227972 @default.
• W3047101097 cites W2891215230 @default.
• W3047101097 cites W2891924787 @default.
• W3047101097 cites W2899573186 @default.
• W3047101097 cites W2909448500 @default.
• W3047101097 cites W2910994117 @default.
• W3047101097 cites W2916703154 @default.
• W3047101097 cites W2925007462 @default.
• W3047101097 cites W2948970280 @default.
• W3047101097 cites W2949403516 @default.
• W3047101097 cites W2958488683 @default.
• W3047101097 cites W2989601927 @default.
• W3047101097 cites W3005794305 @default.
• W3047101097 cites W3006007810 @default.
• W3047101097 cites W3037669104 @default.
• W3047101097 doi "https://doi.org/10.3390/cancers12082171" @default.
• W3047101097 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7464787" @default.
• W3047101097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32764229" @default.
• W3047101097 hasPublicationYear "2020" @default.
• W3047101097 type Work @default.
• W3047101097 sameAs 3047101097 @default.
• W3047101097 citedByCount "16" @default.
• W3047101097 countsByYear W30471010972021 @default.
• W3047101097 countsByYear W30471010972022 @default.
• W3047101097 countsByYear W30471010972023 @default.
• W3047101097 crossrefType "journal-article" @default.
• W3047101097 hasAuthorship W3047101097A5013229327 @default.
• W3047101097 hasAuthorship W3047101097A5019797686 @default.
• W3047101097 hasAuthorship W3047101097A5024647317 @default.
• W3047101097 hasAuthorship W3047101097A5025363729 @default.
• W3047101097 hasAuthorship W3047101097A5027209719 @default.
• W3047101097 hasAuthorship W3047101097A5031935302 @default.
• W3047101097 hasAuthorship W3047101097A5041218872 @default.
• W3047101097 hasAuthorship W3047101097A5046863485 @default.
• W3047101097 hasAuthorship W3047101097A5049083520 @default.
• W3047101097 hasAuthorship W3047101097A5052872662 @default.
• W3047101097 hasAuthorship W3047101097A5065317886 @default.
• W3047101097 hasAuthorship W3047101097A5067045168 @default.
• W3047101097 hasAuthorship W3047101097A5068120048 @default.
• W3047101097 hasAuthorship W3047101097A5069030466 @default.
• W3047101097 hasAuthorship W3047101097A5077770534 @default.
• W3047101097 hasAuthorship W3047101097A5088300504 @default.
• W3047101097 hasAuthorship W3047101097A5089465112 @default.
• W3047101097 hasBestOaLocation W30471010971 @default.
• W3047101097 hasConcept C104317684 @default.
• W3047101097 hasConcept C114684123 @default.

• next